Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,110 | 225 | 0 | 0 | 0 |
| Gross Profit | 1,110 | 225 | N/A | N/A | N/A |
| Operating Expenses | 45,198 | 20,290 | 20,775 | 20,936 | 24,082 |
| Operating Income | -44,088 | -20,065 | -20,775 | -20,936 | -24,082 |
| Other Income | 695 | 793 | 600 | 661 | 799 |
| Pre-tax Income | -43,393 | -19,272 | -20,175 | -20,275 | -23,283 |
| Net Income Continuous | -43,393 | -19,272 | -20,175 | -20,275 | -23,283 |
| Net Income | $-43,393 | $-19,272 | $-20,175 | $-20,275 | $-23,283 |
| EPS Basic Total Ops | -0.20 | -0.09 | -0.09 | -0.12 | -0.14 |
| EPS Basic Continuous Ops | -0.20 | -0.09 | -0.08 | -0.12 | -0.14 |
| EPS Diluted Total Ops | -0.20 | -0.09 | -0.09 | -0.12 | -0.14 |
| EPS Diluted Continuous Ops | -0.20 | -0.09 | -0.08 | -0.12 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.09 | -0.12 | -0.12 | -0.14 |
| EBITDA(a) | $-42,390 | $-18,302 | $-18,948 | $-18,961 | $-21,729 |